Philippines' FDA allows wider gap between Sputnik V doses
The Peninsula
MANILA: The Philippines will allow a 42-day interval between doses of Russia's Sputnik V COVID-19 vaccine, the head of its Food and Drug Administration (FDA) said on Wednesday, though still below the 90-day interval recommended by the vaccine manufacturer.
FDA Chief Rolando Enrique Domingo told Reuters the Gamaleya Institute's request to widen the time interval between two vaccine doses to 90 days from 21 would have to be "re-evaluated" as the Russian vaccine maker submitted more data to support it. "Our vaccine experts recommended a maximum dose interval of 42 days. No problem in delaying the second dose, but if we give it within 42 days we have reason to believe that the results are going to be very good," Domingo told a separate briefing.More Related News